Conditions: Chronic Myeloid Leukemia
Keywords: Newly diagnosed, Ph+ chronic myeloid leukemia, CML-CP
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 267
Healthy volunteers: no

Brief summary:
The study will compare the efficacy and safety of Nilotinib versus Imatinib in newly diagnosed Chinese patients with CML-CP.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Nilotinib intervention 2: Imatinib
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: